Taigen Biopharmaceuticals Holdings Ltd (4157) — Working Capital to Net Assets Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Working Capital to Net Assets ratio of 95.9% as of September 2025. Working capital of NT$856.42 Million (current assets of NT$943.94 Million minus current liabilities of NT$87.52 Million) is measured against net assets of NT$892.68 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Taigen Biopharmaceuticals Holdings Ltd's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Taigen Biopharmaceuticals Holdings Ltd Working Capital to Net Assets (2010–2024)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2024. As of September 2025, the ratio stands at 95.9%, reflecting working capital of NT$856.42 Million against net assets of NT$892.68 Million TWD. Check Taigen Biopharmaceuticals Holdings Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Taigen Biopharmaceuticals Holdings Ltd (2010–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2024, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Taigen Biopharmaceuticals Holdings Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 96.1% | NT$1.04 Billion | NT$1.08 Billion | NT$1.09 Billion | NT$46.08 Million | ▲ +1.1 pp |
| 2023 | 95.0% | NT$1.06 Billion | NT$1.12 Billion | NT$1.11 Billion | NT$47.89 Million | ▲ +2.4 pp |
| 2022 | 92.6% | NT$897.91 Million | NT$970.03 Million | NT$949.24 Million | NT$51.32 Million | ▲ +1.5 pp |
| 2021 | 91.1% | NT$1.14 Billion | NT$1.25 Billion | NT$1.23 Billion | NT$89.88 Million | ▲ +24.0 pp |
| 2020 | 67.1% | NT$296.69 Million | NT$442.18 Million | NT$391.60 Million | NT$94.91 Million | ▼ -8.3 pp |
| 2019 | 75.4% | NT$614.51 Million | NT$815.18 Million | NT$703.82 Million | NT$89.31 Million | ▲ +5.9 pp |
| 2018 | 69.5% | NT$759.75 Million | NT$1.09 Billion | NT$825.58 Million | NT$65.83 Million | ▼ -0.8 pp |
| 2017 | 70.3% | NT$1.00 Billion | NT$1.42 Billion | NT$1.07 Billion | NT$69.72 Million | ▼ -23.9 pp |
| 2016 | 94.2% | NT$636.30 Million | NT$675.62 Million | NT$757.37 Million | NT$121.06 Million | ▼ -2.3 pp |
| 2015 | 96.5% | NT$426.26 Million | NT$441.60 Million | NT$559.75 Million | NT$133.48 Million | ▼ -7.7 pp |
| 2014 | 104.2% | NT$888.23 Million | NT$852.14 Million | NT$1.04 Billion | NT$147.99 Million | ▼ -51.7 pp |
| 2013 | 155.9% | NT$239.72 Million | NT$153.77 Million | NT$429.23 Million | NT$189.51 Million | ▲ +23.0 pp |
| 2012 | 132.9% | NT$495.48 Million | NT$372.80 Million | NT$678.30 Million | NT$182.82 Million | ▲ +41.6 pp |
| 2011 | 91.3% | NT$468.81 Million | NT$513.21 Million | NT$554.89 Million | NT$86.08 Million | ▼ -12.8 pp |
| 2010 | 104.2% | NT$-4.47 Billion | NT$-4.29 Billion | NT$923.10 Million | NT$5.39 Billion | — |